Biopharmaceuticals
News Release - July 2, 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Source: Theravance
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.